Please login to the form below

Not currently logged in
PMLiVE Top Pharma List

Data by

Global Data


Revenue 2014


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Otsuka's 2012 sales performance.

First digital medicine approved in the US

First digital medicine approved in the US

The FDA has approved Otsuka and Proteus Health’s Abilify MyCite, a pill with an embedded sensor that monitors whether patients have ingested the medication. ... For now Proteus and Otsuka are not discussing the pricing of the new product and says they

Tools for the digital world

Tools for the digital world In May Proteus and Otsuka Pharmaceutical Co resubmitted a New Drug Application for the drug-device combination product of Ablify (aripiprazole) embedded with a Proteus ingestible sensor in a single tablet.

Lundbeck and Otsuka start phase III for Rexulti in bipolar

Lundbeck and Otsuka start phase III for Rexulti in bipolar Lundbeck and Otsuka start phase III for Rexulti in bipolar. Drug is also in phase II trial to treat PTSD patients. ... Abilify. Lundbeck and Otsuka are also evaluating the drug in a phase II trial involving patients with post-traumatic stress disorder

Deal Watch May 2017

So when Akebia in December 2016 licensed vadadustat to Otsuka only for the US, there was every prospect of challenges in alliance management. ... 1, 050. Akebia (US). Otsuka (JP). Licence expansion selected countries. Vadadustat in phase 3 for treatment

Novartis tie-up with IBM Watson Health in breast cancer

Novartis tie-up with IBM Watson Health in breast cancer For IBM the deal marks the latest stage in expanding a client base that already includes work with Otsuka and Novo Nordisk, using healthcare data in psychiatric disorders and diabetes respectively.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit

Featured jobs

Subscribe to our email news alerts


Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

The big dilemma in international digital pharma marketing
How to get consistent international marketing while meeting local affiliates’ needs....
Why pharma content marketing campaigns should be agile
Agile pharma content marketing is simply about responding to customer needs, rather than your own whims....
Grabbing your audience*
Highlighting one of our recent pieces of work - a powerful disease awareness film created in partnership with Watchable Films...